S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of celecoxib may be effective in preventing
breast cancer.
PURPOSE: This randomized phase II trial is studying how well celecoxib works in preventing
breast cancer in premenopausal women who are at risk for developing the disease.